Despite significant advances in the treatment of diabetic foot ulcers and below-the-knee critical ischemia, there are ongoing efforts to achieve a method with low complication, high success rate and persistence of long-term effects.
The aim of the study was to examine the outcome of angioplasty in patients with below-the-knee critical ischemia referred to Hospital.
Material and methods. This semi-experimental study conducted on diabetics patients treated with PTA (Percutaneous transluminal angioplasty) with critical ischemia of lower limbs referred to Sina Hospital. After discharge, the patients were followed weekly for the first month and then monthly up to 12 months. The procedure short-term effects were examined through evaluation of wound healing as well as patients' recovery and pain relief, after one month. Given the distribution type, parametric and non-parametric test were used to compare the results before and after treatment. Pearson's correlation coefficient was used to determine the correlation between variables.
Results. Twenty four patients participated in this study. The mean ankle-brachial index (ABI) at baseline was 0.55±0.17. A month after angioplasty, the index increased statistically significant to 0.93±0.16. The mean health score expressed by the patients at baseline was 5.48±1.39. A month after angioplasty, it was significantly increased (6.32±1.24). The mean pain score before enrollment was 6.68±2.52 (according to VAS scale). There was a significant decrease over time (3.45±1.13). The overall mean score of all patients at Rutherford Classification was 3.88±0.63 at baseline. During the 1st month and 6th month follow-up, it was changed to Class 0 that was statistically significant in the first month.
Conclusions. This study represents the mid-term outcomes of PTA. Although PTA treatment was associated with improved pain scores, satisfaction with health, classification of limb ischemia and diabetic foot ulcers, the effects only remain short-term and mid-term. However, long-term efficacy of PTA needs to be investigated further.
4. Beach KW, Brunzell JD, Conquest LL, Strandness DE: The correlation of arteriosclerosis obliterans with lipoproteins in insulin-dependent and non insulin-dependent diabetes. Diabetes 1979; 28: 836-40.
5. West KW: Epidemiology of diabetes and its vascular complications: report to U.S. National Commission on Diabetes. Scope and Impact of Diabetes 1975; 3: 56-60.
6. Feiring AJ, Wesolowski AA, Lade S: Primary stent-supported angioplasty for treatment of below -knee critical limb ischemia and severe claudication: early and one-year outcomes. J Am Coll Cardiol 2004 Dec 21; 44(12): 2307-14.
7. Alber M, Romiti M, Brochado-Neto FC, Pereira CAB: Meta-analysis of alternate autogenous vein bypass grafts to infrapopliteal arteries. J Vasc Surg 2005; 42: 449-55.
8. van der Zaag ES, Legemate DA, Prins MH et al.: Angioplasty or bypass for super.cial femoral artery disease? A randomised controlled trial. Eur J Vasc Endovasc Surg 2004; 28: 132-37.
9. Papavassiliou VG, Walker SR, Bolia A et al.: Techniques for the endovascular management of complications following lower limb percutaneous transluminal angioplasty. Eur J Vasc Endovasc Surg 2003; 25: 125-30.
10. Derubertis BG, Pierce M, Ryer EJ et al.: Reduced primary patency rate in diabetic patients after percutaneous intervention results from more frequent presentation with limb-threatening ischemia. J Vasc Surg 2008; 47: 101-08.
11. Micari A, Vadalà G, Biamino G: Update on the TURBO BOOSTER spectranetics laser for lower extremity occlusive disease. J Cardiovasc Surg (Torino) 2010; 51: 233-43.
12. Adam DJ, Beard JD, Cleveland T et al.: BASIL trial participants. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 2005; 366: 1925-34.
13. Hall KV: The great saphenous vein used in situ as an arterial shunt after extirpation of the vein valves. A preliminary report. Surgery 1962 Apr; 51: 492-95.
14. Hanna GP, Fujise K, Kjellgren O et al.: Infrapopliteal transcatheter interventions for limb salvage in diabetic patients: importance of aggressive interventional approach and role of transcutaneous oximetry. J Am Coll Cardiol 1997 Sep; 30(3): 664-69.
15. Dorros G, Jaff MR, Dorros AM et al.: Tibioperoneal (out.ow lesion) angioplasty can be used as primary treatment in 235 patients with critical limb ischemia: five-year follow-up. Circulation 2001; 104: 2057-62.
16. Kudo T, Chandra FA, Ahn SS: The effectiveness of percutaneous transluminal angioplasty for the treatment of critical limb ischaemia: a10 year experience. J Vas Surg 2005; 41: 423-35.
17. Krankenberg H, Sorge I, Zeller T, Tubler T: Percutaneous transluminal angioplasty of infrapopliteal arteries in patients with intermittent claudication: acute and one-year results. Catheter Cardiovasc Interv 2005 Jan; 64(1): 12-17.
18. Soder HK, Manninen HI, Jaakkola P et al.: Prospective trial of infrapopliteal artery balloon angioplasty for critical limb ischemia: angiographic and clinical results. J Vasc Interv Radiol 2000 Sep; 11(8): 1021-31.
19. Taylor LMJ, Porter JM: The clinical course of diabetics who require emergent foot surgery because of infection or ischemia. J Vasc Surg 1987; 6: 454-59.
20. Pecoraro RE, Ahroni JH, Boyko EJ, Stensel VL: Chronology and determinants of tissue repair in diabetic lower-extremity ulcers. Diabetes 1991; 40: 1305-13.
21. Tan M, Pua U, Wong DE et al.: Critical limb ischaemia in a diabetic population from an Asian Centre: angiographic pattern of disease and 3-year limb salvage rate with percutaneous angioplasty as first line of treatment. Biomed Imaging Interv J 2010 Oct-Dec; 6(4): e33.
22. Faglia E, Clerici G, Clerissi J et al.: Early and five-year amputation and survival rate of diabetic patients with critical limb ischemia: data of a cohort study of 564 patients. Eur J Vasc Endovasc Surg 2006; 32: 90-94.
24. McDaniel MD, Cronenwett JL: Basic data related to the natural history of intermittent claudication. Ann Vasc Surg 1989; 3: 273-77.
25. Chesire NJ, Wolfe JH, Noone MA et al.: The economics of femorocrural reconstruction for critical leg ischaemia with and without autologous vein. J Vasc Surg 1992; 15: 167-74.
26. Balmer H, Mahler F, Do DD et al.: Balloon angioplasty in chronic critical limb ischemia: factors affecting clinical and angiographic outcome. J Endovasc Ther 2002 Aug; 9(4): 403-10.
27. Faglia E, Dalla Paola L et al.: Peripheral angioplasty as the first-choice revascularization procedure in diabetic patients with critical limb ischemia: prospective study of 993 consecutive patients hospitalized and followed between 1999 and 2003. Eur J Vasc Endovas Surg 2005; 29: 620-27.
28. Bosch JL, Hunink MG: Meta-analysis of the results of percutaneous transluminal angioplasty and stent placement for aortoiliac occlusive disease. Radiology 1997 Jul; 204(1): 87-96.
29. Gandini R, Fabiano S, Chiocchi M et al.: Percutaneous treatment in iliac artery occlusion: longterm results. Cardiovasc Intervent Radiol 2008 Nov-Dec; 31(6): 1069-76.
30. Gargiulo M, Maioli F, Ceccacci T et al.: What's next after optimal infrapopliteal angioplasty? Clinical and ultrasonographic results of a prospective single-center study. J Endovasc Ther 2008 Jun; 15(3): 363-69.
31. Mlekusch W, Schillinger M, Sabeti S et al.: Clinical outcome and prognostic factors for ischaemic ulcers treated with PTA in lower limbs. Eur J Vasc Endovasc Surg 2002 Aug; 24(2): 176-81.